Molecular biomarkers to guide precision medicine in localized prostate cancer

被引:21
|
作者
Smits, Minke [1 ]
Mehra, Niven [1 ]
Sedelaar, Michiel [1 ]
Gerritsen, Winald [1 ]
Schalken, Jack A. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Urol & Oncol, Nijmegen, Netherlands
关键词
Active surveillance; biochemical relapse; biomarkers; disease-specific survival; localized prostate cancer; molecular; overall survival; CIRCULATING TUMOR-CELLS; CYCLE PROGRESSION-SCORE; BET BROMODOMAIN PROTEINS; COPY NUMBER ALTERATIONS; ANDROGEN RECEPTOR; BIOCHEMICAL RECURRENCE; PROGNOSTIC VALUE; RADICAL PROSTATECTOMY; MUTATIONAL LANDSCAPE; PROMOTER METHYLATION;
D O I
10.1080/14737159.2017.1345627
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction: Major advances through tumor profiling technologies, that include next-generation sequencing, epigenetic, proteomic and transcriptomic methods, have been made in primary prostate cancer, providing novel biomarkers that may guide precision medicine in the near future. Areas covered: The authors provided an overview of novel molecular biomarkers in tissue, blood and urine that may be used as clinical tools to assess prognosis, improve selection criteria for active surveillance programs, and detect disease relapse early in localized prostate cancer. Expert commentary: Active surveillance (AS) in localized prostate cancer is an accepted strategy in patients with very low-risk prostate cancer. Many more patients may benefit from watchful waiting, and include patients of higher clinical stage and grade, however selection criteria have to be optimized and early recognition of transformation from localized to lethal disease has to be improved by addition of molecular biomarkers. The role of non-invasive biomarkers is challenging the need for repeat biopsies, commonly performed at 1 and 4 years in men under AS programs.
引用
收藏
页码:791 / 804
页数:14
相关论文
共 50 条
  • [1] Genomic biomarkers to guide precision radiotherapy in prostate cancer
    Sutera, Philip
    Deek, Matthew P.
    Van Der Eecken, Kim
    Wyatt, Alexander W.
    Kishan, Amar U.
    Molitoris, Jason K.
    Ferris, Matthew J.
    Siddiqui, M. Minhaj
    Rana, Zaker
    Mishra, Mark V.
    Kwok, Young
    Davicioni, Elai
    Spratt, Daniel E.
    Ost, Piet
    Feng, Felix Y.
    Tran, Phuoc T.
    [J]. PROSTATE, 2022, 82 : S73 - S85
  • [2] Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline
    Eggener, Scott E.
    Rumble, R. Bryan
    Armstrong, Andrew J.
    Morgan, Todd M.
    Crispino, Tony
    Cornford, Philip
    van der Kwast, Theodorus
    Grignon, David J.
    Rai, Alex J.
    Agarwal, Neeraj
    Klein, Eric A.
    Den, Robert B.
    Beltran, Himisha
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (13) : 1474 - +
  • [3] Biomarkers in localized prostate cancer
    Ferro, Matteo
    Buonerba, Carlo
    Terracciano, Daniela
    Lucarelli, Giuseppe
    Cosimato, Vincenzo
    Bottero, Danilo
    Deliu, Victor M.
    Ditonno, Pasquale
    Perdona, Sisto
    Autorino, Riccardo
    Coman, Ioman
    De Placido, Sabino
    Di Lorenzo, Giuseppe
    De Cobelli, Ottavio
    [J]. FUTURE ONCOLOGY, 2016, 12 (03) : 399 - 411
  • [4] Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline Summary
    Eggener, Scott E.
    Rumble, R. Bryan
    Beltran, Himisha
    [J]. JCO ONCOLOGY PRACTICE, 2020, 16 (06) : 340 - +
  • [5] Emerging biomarkers and molecular targets for precision medicine in cervical cancer
    Garg, Pankaj
    Krishna, Madhu
    Subbalakshmi, Ayalur Raghu
    Ramisetty, Sravani
    Mohanty, Atish
    Kulkarni, Prakash
    Horne, David
    Salgia, Ravi
    Singhal, Sharad S.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [6] Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer
    Davoudi, Fatemeh
    Moradi, Afshin
    Becker, Therese M. M.
    Lock, John G. G.
    Abbey, Brian
    Fontanarosa, Davide
    Haworth, Annette
    Clements, Judith
    Ecker, Rupert C. C.
    Batra, Jyotsna
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (10) : 1451 - 1471
  • [7] Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer
    Fatemeh Davoudi
    Afshin Moradi
    Therese M. Becker
    John G. Lock
    Brian Abbey
    Davide Fontanarosa
    Annette Haworth
    Judith Clements
    Rupert C. Ecker
    Jyotsna Batra
    [J]. Current Treatment Options in Oncology, 2023, 24 : 1451 - 1471
  • [8] Precision medicine in prostate cancer
    Fujita, Kazutoshi
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S276 - S276
  • [9] Precision medicine for prostate cancer
    Galazi, Myria
    Rodriguez-Vida, Alejo
    Ng, Tony
    Mason, Malcolm
    Chowdhury, Simon
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (11) : 1305 - 1315
  • [10] Precision Medicine in Prostate Cancer
    Sakamoto, Shinichi
    Nisiho, Kazuto
    Ichikawa, Tomohiko
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 34 - 34